The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IWWM-11 2022 | The importance of studying RNA expression in rare diseases such as WM
Jonas Paludo, MD, Mayo Clinic, Rochester, MN, briefly explains the importance of studying RNA expression in rare diseases such as Waldenström’s macroglobulinemia (WM), and how this information may provide therapeutic options for patients beyond BTK inhibition. This interview took place at the 11th International Workshop on Waldenström’s Macroglobulinemia (IWWM-11), held in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Karyopharm and Biofourmis – both research funding to my institution
